Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

My board review cards > Neurology VII-XVIII > Flashcards

Neurology VII-XVIII Flashcards

1
Q

Selective neuronal necrosis - most common injury?

A

Hypoxic ischemic encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Selective neuronal necrosis - pathogenesis and when to see change occur?

A
  • Oxygen deprivation
  • Potential role of excitatory AA - ASPARATATE + GLUTAMATE
  • Change 24-36 hours after injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Selective neuronal necrosis - distribution?

A
  • Diffuse
  • Cerebral cortex -> deep nuclear structures (BASAL GANGLIA, THALAMUS, GOLLUS PALLIDUS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Selective neuronal necrosis - clinical outcome?

A
  • Pyramidal cerebral palsy
  • Mental deficiency, feeding difficulties, seizures, ataxia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Parasagittal cerebral injury - pathogenesis?

A
  • Usually ischemic lesion in full term infants
  • Disturbance in cerebral perfusion s/t systemic hypotension, hypoxemia, acidosis (severe perinatal depression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parasagittal cerebral injury - distribution?

A
  • Border areas perfused by anterior, middle , posterior cerebral arteries (border areas susceptible to decreased in cerebral perfusion pressure)
  • Usually bilateral and symmetrical, however one side can be more affected
  • Parasagittal supermedial areas - posterior cerebral hemisphere more often involved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Parasagittal cerebral injury - clinical outcome?

A
  • SPASTIC QUADRIPLEGIA (PROMIXAL LIMBS UPPER > LOWER)
  • Weakness shoulder girdle
  • If posterior artery affected - deficits in auditory, visual, spatial, language abilities
  • Cognitive deficits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Focal or multifocal ischemia - distribution?

A
  • Usually ischemic lesion in full term infants
  • Unilateral 90% > bilateral 10%
  • Left hemisphere most commonly affected - LEFT MIDDLE CEREBRAL ARTERY most common site
  • left MCA 60% > right MCA 20% > bilateral MCA 10% > other arteries 5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Focal or multifocal ischemia - etiology?

A
  • Unknown 50% vs Perinatal asphyxia 33%
  • Others 2% each - trauma, meningitis, polycythemia, hypernatremia/dehydration, postnatal hypotension, CHD, protein C def, protein S def, ATIII def, anti-PL Ab, intrauterine cocaine exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Focal or multifocal ischemia - neonatal presentation?

A
  • Hypotonia vs hypertonia: PROXIMAL LIMBS UPPER > LOWER
  • Seizures 12-24 hours of life; associated with apnea
  • Decr level consciousness
  • Periodic breathing or resp failure
  • Intact pupillary response and oculomotor response
  • Feeding dysfunction common - abnormal sucking, swallowing, tongue movements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Focal or multifocal ischemia - clinical outcome?

A
  • Hemiplegia or quadriplegia
  • Cognitive deficits
  • Seizure disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Periventricular hemorrhage - risks?

A

Prematurity
IVH
Severe illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Periventricular hemorrhage - location?

A

Usually large, asymmetric, mostly unilateral
Doral and lateral to external angle of lateral ventricles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Periventricular hemorrhage - pathogenesis?

A
  • Caused by hemorrhagic necrosis of periventricular white matter
  • Directly related to IVH because:
    1. 80% associated large asymmetric IVH
    2. Lesion usually same side as IVH
    3. Develops after IVH occurs (PEAK TIME 4TH DAY OF LIFE)

IVH obstructs blood flow in terminal vein, leading to venous infarction in distribution of MEDULLARY VEINS (drain cerebral white matter into terminal vein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Periventricular hemorrhage - how to diagnose?

A

Ultrasound d/t high sensitivity and resolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Periventricular hemorrhage - clinical outcome?

A

Spastic hemiparesis or asymmetric quadriparesis UPPER = LOWER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Periventicular leukomalacia - risks?

A

Prematurity (rarely >32w)
Severe illness
IVH
Maternal fetal infection
Prolonged hypoxia (postnatal systemis hypotension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Periventicular leukomalacia - pathogenesis?

A
  • Caused by focal injury and necrosis of periventricular white matter

4 main physiologic features that predispose premature infants:
1) Periventricular vascular anatomic factors
2) CPP dependent on systemic BP
3) Increased vulnerability of actively differentiating or myelinating periventricular glial cells
4) Insult (vascular, inflammatory) leading to oligodendroglial cell death -> myelin deficiency

May develop lateral ventricular dilation in presence of myelin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Periventicular leukomalacia - how to diagnose?

A

Ultrasound - bilateral linear echodensities adjacent to external angles of lateral ventricles
US findings not evident until 1 month or later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Periventicular leukomalacia - clinical outcome?

A

SPASTIC DIPLEGIA (LOWER > UPPER) most common clinical sequela
Cognitive and visual deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Subdural hemorrhage - pathogenesis?

A

Uncommon
Full term > preterm
Caused by trauma and tearing of veins and venous sinuses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Subdural hemorrhage - clinical presentation?

A

Posterior fossa / Infratentorial:
- Severe hemorrhage with acute signs: stupor, lateral eye deviation, opisthotonos, apnea, death
- Insidious onset: can be silent for DAYS

Over convexities:
- Minimal or no symptoms
- Severe hemorrhage with acute signs: seizures, lateral eye deviation, nonreactive dilated pupil on side of hematoma, hemiparesis
- Insidious onset: can be silent for MONTHS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Subdural hemorrhage - how to diagnose?

A
  • CT: safe, quick, details injury
  • MRI: views of posterior fossa
  • US: not effective
  • Avoid LP, may provoke herniation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Subdural hemorrhage - prognosis?

A

Severe infratentorial: extremely poor px

Less severe infratentorial: variable
- if tx’d - 80-90% normal outcome
- 10-15% serious sequelae including hydrocephalus req shunt
- 5% mortality

Convexity: favorable; incr risk for focal cerebral signs and hydrocephalus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Subarachnoid hemorrhage

A

Premature > full term
Asymptomatic
Possible early onset refractory seizures on 2nd postnatal day
Dx CT
Px good

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Cerebellar hemorrhage

A

Uncommon
Premature > full term
Serious; sx brainstem compression and irritation = Respiratory irregularities, apnea, bradycardia, lateral deviation eyes
Dx US, CT more definitive
Px long term neurodev deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Intraventricular hemorrhage - premature infants

A

Common
Premature 15% > full term
>32w severe IVH 5-6%

Location: germinal matrix, subependymal germinal matrix
Risks multifactorial (dev fragility, vulnerability and vascularity germinal matrix, fluctuating cerebral blood flow, incr CVP, impaired autoregulation CBF, coagulation disturbance)

Clinical: 50% occur in first 24h, 90% by 72h; variable presentation

Dx: serial US
Management: monitor for PHH and PVL
Px: depends on severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Intraventricular hemorrhage - full term infants

A

Rare 2% full term infants
Location: germinal matrix, subependymal germinal matrix
Risks: trauma, asphyxia, majority no definable cause
Clinical: irritability, lethargy, apnea, seizures
Dx: US or CT
Management: monitor for PHH
Px: 55% neurologically normal; 40% severe neurologic sequelae, 50% shunt; 5% mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Caput succedaneum

A

Common
Hemorrhagic edema CROSSES SUTURE LINES
Soft, superficial, pitting
Vertex of head, associated with cranial molding
Spontaneously resolves over SEVERAL DAYS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Cephalohematoma

A

1-2% all births
Boys > girls, primiparous mother, delivery forceps
BLEEDING AT SUBPERIOSTEAL CONFINED BY SUTURE LINES
Firm, tense
Underlying skull fracture 10-25%
Spontaneously resolves FEW WEEKS TO MONTHS
Monitor hyperbilirubinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Subgaleal

A

Less common
BLEEDING OF EMISSARY VEINS BETWEEN SCALP AND DURAL SINUSES
BLEEDING BETWEEN SKULL PERIOSTEUM AND APONEUROSIS
Blood can dissect through subcutaneous tissue of neck and behind ear; up to 30% blood can be sequestered
Firm or fluctuant
Spontaneously resolves 2-3 WEEKS
Monitor hyperbilirubinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Extradural

A

Rare
SUPERIOSTEAL on INNER SURFACE OF SKULL
Caused by disruption MIDDLE CEREBRAL ARTERY OR VEIN and VENOUS SINUS
Linear skull fractures and cephalohematomas may co-exist
Early signs increased ICP
Dx: emergent CT shows CONVEX SHAPED hemorrhagic lesion
Management: evacuation aspiration or surgical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Brachial plexus injuries - which root most vulnerable?

A

Upper roots most vulnerable - first C5 then C6 and so on
90% unilateral right > left
Risks: LGA, complication labor and delivery process
Management: prevent contractures - PT, eval 3 months if no recovery

Px: 88% normal by 4 months, 92% normal by 1 year
- w/ full recovery: improvement by 2 weeks, recover by 6 months
- if residual impairment at 15 months, usually persists
- Potential morbidity: impaired function + strength, muscle atrophy, contractures, impaired growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Erb-Duchenne Palsy

A

PROXIMAL C5-C7 injury
Most common 90%
“Waiter’s tip” = arm ADduction + internally rotated, extension elbow, pronation forearm, flexed wrist + fingers
Biceps reflex absent
Grasp reflex INTACT (diff Klumpke)
Shoulder moro absent
Hand moro PRESENT (diff Klumpke)

C4/C5 = phrenic nerve palsy
- Resp distress + decr diaphragm movement = CXR w/ elevated hemidiaphragm

C7 = flexion deformity of hand, winged scapula, sensory loss over deltoids + radial aspect upper arm, decr temp + perspiration
- Same moro + grasp reflex as above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Klumpke’s Palsy

A

DISTAL C8-T1 injury
Less common
Rare isolated injury, often upper roots involved -> total palsy
Flexors wrist + fingers weak = wrist + fingers extended in neutral position
Biceps reflex absent
Grasp reflex ABSENT (diff Erbs)
Complete moro ABSENT (diff Erbs)

T1 = unilateral Horner’s syndrome
- Miosis + ptosis + anhidrosis + decreased pigmentation of iris

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Spinal cord injury

A

Traction + excessive rotation at delivery
Flaccid weakness LOWER > UPPER extremities
Sensory level at lower neck to upper trunk
Paradoxical respirations
Paralyzed abd muscles w/ rounded, distended appearance
Atonic anal sphincter
Distended bladder

Dx: US then MRI better delineate lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Facial nerve palsy

A

CN VII most common facial nerve injury during delivery
Caused by nerve compression w/ hemorrhage + edema of nerve sheath
Weakness lower + upper facial muscles, unilateral left 75% > right
Asymmetric cry
Lack of complete eyelid closure, inability to wink, flat nasolabial fold on paretic side
Px good, recover 1-3 weeks
Management: eyedrops, tape paralytic eyelid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Lower motor neuron disorders - major categories

A
  1. Anterior horn cell - ex. SMA Type 1 (Werdnig-Hoffman Disease)
  2. NMJ - ex. Acquired transient neonatal myasthenia graves, Congenital myasthenia graves
  3. Congenital myopathy
  4. Muscular dystrophy - ex. Congenital myotonic dystrophy
  5. Metabolic and multisystem disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Spinal muscular atrophy type I - genetics, pathophysiology, history?

A

= Werdnig-Hoffman Disease
Genetics: AR, chromosome 5 (“S” = “5”)
Patho: Degeneration anterior horn cell
Hx: Decreased fetal movements, affected sibling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Spinal muscular atrophy type I - clinical presentation?

A
  • Onset < 6 months
  • Severe generalized hypotonia w/ marked head lag -> LEGS > ARMS; PROXIMAL > DISTAL
  • Areflexia
  • Bulbar weakness = poor suck and swallow, weak cry, TONGUE FASCICULATIONS
  • Facial sparing- Classic “frog-leg” position
  • Bell-shaped chest w/ abdominal breathing
  • Upper extremities ABducted + rotated = “jug handle” appearance
  • Normal extraocular movements, sensory exam, sphincter fxn, diaphragmatic fxn (vent support less likely)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Spinal muscular atrophy type I - diagnosis and prognosis?

A

Dx:
CPK normal
EMG nonspecific denervation, fasciculations, fibrillations
Muscle biopsy w/ atrophy of motor units
Nerve conduction velocity normal

Px: death < 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Acquired transient neonatal myasthenia gravis - epidemiology and pathophysiology?

A

Epi: 10-20% infants born to mothers w/ MG (no correlation to severity and duration of maternal disease

Patho: immune process involving NMJ
- TRANSIENT
- neonate affected by maternally transmitted anti-Ach R Ab from mother with MG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Acquired transient neonatal myasthenia gravis - clinical presentation, duration?

A
  • Intrauterine hypotonia and weakness -> decreased fetal movement, arthrogryposis, polyhydramnios, pulmonary hypoplasia
  • Facial weakness, swallowing difficulties, feeding difficulties
  • 2/3 resp failure, inability to management secretions

Duration: mean 18 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Acquired transient neonatal myasthenia gravis - diagnosis and treatment?

A

Dx:
- Maternal history
- CPK normal
- EMG progressive decline amplitude w/ repetitive nerve stimulation, then return to baseline after period of rest or neostigmine
- Muscle biopsy normal
- Nerve conduction velocity normal

Tx: anticholinesterase therapy = neostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Congenital neonatal myasthenia gravis - pathogenesis and types?

A

genetic defect in NMJ
NOT TRANSIENT

2 types:
1) Congenital myasthenia
2) Familial infantile myasthenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Congenital myasthenia - pathophysiology, clinical presentation, diagnosis?

A

Genetics: AR

Path: deficiency of ENDPLATE acetylcholine R

Clinical:
- Less severe than familial infantile
- Sx by few weeks of life
- Ptosis, ophthalmoplegia, facial weakness, poor suck and cry

Dx: Similar to acquired transient MG
- CPK normal
- EMG progressive decline amplitude w/ repetitive nerve stimulation, then return to baseline after period of rest or neostigmine
- Muscle biopsy normal
- Nerve conduction velocity normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Familial infantile myasthenia - pathophysiology, clinical presentation, diagnosis?

A

Genetics: AR rare

Path: deficiency in PRESYNAPTIC Ach synthesis or packaging into vesicles

Clinical:
- Can be severe
- Hypotonia, resp failure, apnea, severe feeding difficulties, facial weakness, ptosis
- Oculomotor less affected than congenital
- Improvement with age

Dx:
- EMG fatigue with prolonged stimulation of faster rates

48
Q

Congenital myotonic dystrophy - genetics, risks, pathogenesis, history?

A

Genetics: AD, chromosome 19
- Trinucleotide repeat CTG, severity determined by number of repeats
- almost entirely inherited from MOTHER

Risks: more severe and earlier onset of mother -> greater risk

Path: altered protein in muscle -> dysfunctional Na and K channels

Mat hx: inability to open eyes completely after shutting tight, delayed release hand grip

Pregnancy hx: polyhydramnios (disordered fetal swallowing), prolonged labor (maternal uterine dysfunction, possibly only sign since mothers often misdiagnosed)

49
Q

Congenital myotonic dystrophy - clinical presentation?

A

First hours to first days of life
Facial diplegia: “tent shaped” mouth, poor oral-motor fxn, resp failure, hypotonia, arthrogryposis, areflexia/hyporeflexia, muscle atrophy

Mental deficiency later in life
Neonatal mortality 40%

50
Q

Congenital myotonic dystrophy - diagnosis?

A

CPK normal
EMG “myotonic” changes “dive-bomber” sound
Muscle biopsy abnormal = small round muscle fibers w/ large nuclei and sparse myofibrils
Nerve conduction velocity normal

51
Q

Riley-Day Syndrome or Familial Dysautonomia - genetics, pathophysiology?

A

Genetics: AR rare
- defect 9q31-33
- Ashkenazi Jewish

Path: disorder peripheral NS
- reduced number small unmyelinated nerves that carry pain, temp, taste, mediate autonomic fxn
- reduced number large myelinated afferent nerve fibers

52
Q

Riley-Day Syndrome or Familial Dysautonomia - clinical presentation?

A

Sx first year of life
Poor suck and swallow with high risk aspiration
Emesis, abd distension, loose bowel movements, irritability
Pale, blotchy skin
Hypotonia, absent corneal reflexes, decreased or absent DTR, hypersensitive pupillary denervation
Decreased tongue papillae
Temp and BP instability

53
Q

Riley-Day Syndrome or Familial Dysautonomia - diagnosis?

A

In normal patient exposed to metacholine eye drops or pilocarpine -> usually no response
In patient with FD / Riley-Day -> leads to miosis
No flare w/ intradermal histamine

54
Q

Prader-Willi Syndrome - genetics and prenatal history?

A

Genetics:
- 70% paternal deletion 15q11.13
- 25% maternal uniparental disomy
- 5% maternal methylation at several loci within 15q11-13 region

Prenatal hx: decreased fetal movement, breech, or both

55
Q

Prader-Willi Syndrome - clinical presentation?

A

Triad: hypotonia + cryptorchidism (or hypogonadism) + poor feeding

Other:
- Small hands and feet
- Almond shaped palpebral tissues
- Thin upper lip
- Light colored hair
- Mild to severe MR, dolichocephaly
- Incr risk scoliosis
- FTT during infancy then obesity from age 6 months to 6 years

56
Q

Arthrogryposis multiplex congenita

A

Fixed joints with limited movements
Associated with other disorders that affects motor fxn
Management: stretching, serial casting, tendon or ligament release procedures

57
Q

Seizures - etiology and treatment?

A

Hypoxia-ischemia
Intracranial hemorrhage
Metabolic - hyponatremia, hypoglycemia, hypocalcemia, metabolic disorders)
Infection
Developmental cerebral anomalies
Drug withdrawal (maternal heroin, methadone, barbiturates)

Treat underlying cause
- Use of anticonvulsants
- Pyridoxine for inherited deficiency

58
Q

Subtle seizures

A
  • Most common
  • Oral, facial, ocular activity
  • “swimming”, “pedaling” limb movements
59
Q

Multifocal seizures

A
  • Clonic activity, jittery of one limb with migration to another part of body non ordered fashion
  • Full term
60
Q

Focal clonic seizures

A
  • Well-localized repetitive
  • Poss associated with metabolic disorder
  • Full term > preterm
61
Q

Tonic seizures

A
  • abrupt change in tone leads to change in posture “posturing” “stiffening” “rigidity”
  • Can be decerebrate posturing
  • Premature
62
Q

Myoclonic seizures

A
  • Rapid sudden shock like jerks of flexion or both arms +/- legs
  • Individual or brief series
  • Premature = term
63
Q

Bumetanide

A

Antiepileptic
Diuretic
Inhibit Na-K-Cl tritransporter used to block Cl channel
Tx temporal lobe seizures

64
Q

Topiramate

A

Antiepileptic
Enhances GABA-activated Cl channels
Inhibits excitatory neurotransmitter

65
Q

Phenobarbital

A

Initial drug of choice

Acts on GABA-A R subunit -> increases time for Cl channels to remain open -> decreasing the cerebral metabolic rate

Therapeutic level 20-40 mg/L
Metabolism liver cytochrome P450

half life:
0-7 days = 100 hours
> 28 days = 0-70 hours

Oral or IV

66
Q

Phenytoin

A

TERATOGEN

Block voltgate-gated Na channels -> block repetitive firing of action potentials

Therapeutic level 10-20 mg/L
Metabolism liver cytochrome P450 + excrete in urine

IV preferred
Oral not ideal - poor GI absorption

Monitor cardiac arrhythmias

67
Q

Keppra

A

Binding to synaptic vesicle protein SV2A -> reduce rate of vesicle release

68
Q

Midazolam

A

Increases GABA activity

69
Q

Vein of Galen Malformation - pathogenesis?

A

Path: persistent median prosencephalic vein of Markowski
- in utero, this vein drains in to Vein of Galen, regress by 2 weeks)

Mechanism of injury:
1. Intracranial steal s/t diastolic run off
2. Hemorrhagic infarction after thrombosis of dilated vein
3. Cerebral ischemia by decr CO after high output CHF
4. Brain atrophy s/t compression

70
Q

Vein of Galen Malformation - clinical presentation?

A
  • 44% present neonatal period
  • Greater size -> Greater amt blood shunted through lesion -> Earlier develop CHF
  • CHF present few hours of life -> worse first 3 days of life, refractory to med mgt
  • Continuous cranial bruit
  • Hydrocephalus 15%: usually not neonatal period s/t aqueduct obstruction or elevated CVP
  • Poss small aneurysm -> HA, focal neurologic deficits syncope later in life
71
Q

Vein of Galen Malformation - diagnosis, management, prognosis?

A

Dx: US doppler, CT, or MRI + angiography

Mgt:
- Minimize CHF
- Embolization transvenous or transarterial, better survival compared to surgery

Px:
- Outcome dep severity CHF and degree brain injury
- Incr risk neurologic deficits
- Morbidity + mortality high

72
Q

Sturge Weber Syndrome

A

Genetics: sporadic

  • PORT-WINE STAIN = pink-purple flat hemangiomata unilateral in 1st division TRIGEMINAL NERVE (CN V) PRESENT AT BIRTH
  • CNS ipsilateral “tramline” intracortical calcifications
  • GLAUCOMA 30% + visual deficits
  • Macrocephaly: hyperplasia of endothelium
  • Seizures GRAND MAL at 2-7 months, mental deficiency
  • Hemiparesis contralateral to facial lesion
  • Worse w/ age
73
Q

Tuberous Sclerosis

A

Genetics: AD
- Chrm 9, 16

  • HYPOPIGMENTED “ASHLEAF” MACULES 50%: +Wood’s lamp, mostly at trunk and buttocks
  • can also have cafe-au-laite spot and shagreen spot
  • Cardiac rhabdomyomas
  • CNS tumors
  • Eye involvement
  • Seizures, mental deficiency
  • Enamel pits in teeth
  • Worse w/ age
74
Q

Neurofibromatosis

A

Genetics: AD
- Chrm 17

  • CAFE-AU-LAIT SPOTS: do not cross midline, SHARP BORDERS, multiple >1.5 cm, RARELY AT BIRTH, 80% by 1 year, 100% by 4 years
  • Freckling axilla, inguinal folds, perineum
  • Macrocephaly, aqueduct stenosis
  • Associated tumors: cutaneous neurofibromas, schwanoma, pheochromocytoma
  • Mildly short stature
  • Seizures, mental deficiency
75
Q

McCune-Albright Syndrome

A

Genetics: sporadic

Triad:
1) IRREGULAR BROWN PIGMENTATIONS “Coast of Maine”
2) FIBROUS DYSPLASIA OF BONES
3) PRECOCIOUS PUBERTY

  • Hyperthyroidism
  • Hyperparathryoidism
  • Pituitary adenomas
76
Q

Von Hippel-Lindau Disease

A

Genetics: AD
- Chrm 3p (short arm)

Path: Overexpression TF hypoxia-inducible factor -> incr tumor growth

  • CNS tumors: hemangioma (mostly cerebellum)
  • Multiple systemic hemangiomata
  • Retinal angiomas
  • Pheochromocytoma
77
Q

Cerebral Palsy - epidemiology?

A

Incidence: 2-3 / 1000
Incr incidence with decr GA + decr BW

Premature infant < 1500 g: 5-20%
24-26w: 6.9%
27-31w: 4.3%
32-34w: < 1%
36w: < 0.1%

78
Q

Cerebral Palsy - risks?

A

Extreme prematurity - most common SPASTIC DIPLEGIA
Symptomatic congenital infection
Bilirubin encephalopathy - incr risk ATHETOID CP
Severe perinatal depression

APGAR poor indicator of infants at risk for brain damage:
- Majority term infants w/ CP had normal APGAR
- Risk of CP 1%, 9%, 57% if APGAR 0-3 at 5, 10, 20 min, respectively

79
Q

Cerebral Palsy - Classification by extremities involved

A

Quadriplegia: all 4 limbs
Hemiplegia: one side (ex right arm + right leg)
Diplegia: legs only OR legs > arms

80
Q

Cerebral Palsy - Classification by neurologic dysfunction

A

Spastic = Pyramidal
Athetoid = Dyskinetic = Extrapyramidal
Mixed
Ataxic

81
Q

Spastic CP = Pyramidal CP

A

Most common 85-90% includes extreme prematurity
INCREASE TONE
INCREASE DTR
GROSS MOTOR AFFECTED
Fine motor not affected
Cognitive fxn not affected

82
Q

Athetoid = Dyskinetic = Extrapyramidal CP

A

7% includes bilirubin encephalopathy
Repetitive uncontrolled involuntary movement

Mixed tone in SAME MUSCLE
GROSS AND FINE MOTOR AFFECTED
Cognitive fxn not affected
Hearing deficits
Speech abnl

2 types:
1) Dystonic
2) Choreoathetoid

83
Q

Mixed CP

A

Mixed tone in VARIOUS MUSCLES

84
Q

Ataxic CP = Atonic CP

A

Least common
DECREASED TONE, poor coordination
DECREASED DTR
SEVERE COGNITIVE DELAY

85
Q

Cerebral Palsy - clinical presentation?

A

Hypotonia, no suck, weak cry > 24h of life Carry 10- to 20-fold incr risk CP
Hypertonia also possible
NON-PROGRESSIVE MOTOR DISORDER
Recognized at 6-18 months corrected age
Incr risk seizures, cognitive dysfunction, sensory impairment, orthopedic deformities, emotional and behavioral disorder

86
Q

Cerebral Palsy - interventions?

A

PT, OT
Assistive devices
Ortho surgery, rhizotomy, brace, botulism toxin injections

87
Q

Mental deficiency - epidemiology and onset?

A

3% population functions 2 standard dev below mean IQ of general population
= IQ < 70-75

Onset:
Prenatal
Perinatal
Postnatal

88
Q

Mental retardation - Prenatal onset

A

Incidence: 60-80%

Single brain defect s/t:
- Microcephaly, hydrocephalus, hydranencephaly (absent cerebral hemispheres), NTD

Multiple defects incl brain s/t:
-Chrm disorder, genetic syndrome (T21, FRAGILE X), hypothyroidism

Infection
Toxin

89
Q

Mental retardation - Postnatal onset

A

Incidence: 10%

Environmental - trauma, lead encephalopathy
Metabolic - hypernatremia, severe hypoglycemia, IEM
Infection - meningitis, encephalitis
Severe hypoxemia
Postnatal stroke
IVH

90
Q

Mental retardation - Perinatal onset

A

Incidence: 8-12%

Trauma
Perinatal depression
Metabolic - kernicterus, severe neonatal hypoglycemia
Infection - meningitis
Intracranial hemorrhage
Stroke

91
Q

Mental retardation - classification old vs new?

A

Old classification - based on IQ:
IQ = Degree of MR
52-68 = Mild
36-51 = Moderate
20-35 = Severe
<20 = Profound

New classification - based on level of support:
Intermittent = constant support not needed
Limited = ongoing support but varying intensity
Extensive = consistent ongoing and daily support
Pervasive = high support for all activities

92
Q

Mental retardation - clinical presentation?

A

Low IQ
Limitations in social, language, self-adaptive fxns
Possible seizures, psych disorders, behavioral abnl
Often depression

93
Q

Mental retardation - Management and prognosis?

A

Early intervention as soon as MR recognized
Family support+ counseling
Identify cause
Consult neuro, speech, SW, OT, PT
Education to max social + occupational skills
Determine support needed

Px: greater degree deficiency -> greater immobility and higher mortality

94
Q

Hearing loss - epidemiology?

A

Profound bilateral 1/1000
Mild-mod 2/1000
Unilateral 1/1000 (LEFT > RIGHT affected)

Premature born < 32w -> incidence 2-4/100 w/ some degree of hearing loss

95
Q

Hearing loss - etiology?

A

Genetic 50%
- 70% AR
- 15% AD
-15% other genetic transmission
- MOST COMMON GENETIC CAUSE HEARING LOSS: CONNEXIN 26 (Cx26) gene mutation 20-30%
- Alport, Pierre Robin, Usher, Pendred, Waardenburg, Treacher Collins, CHARGE, Klippel-Feil sequence, T8, Stickler, T21

Acquired 25%
- Injury intrapartum or permpartum
- S/t hypoxia, infections (meningitis), ischemia, severe hyperbili, complications r/t prematurity, ototoxic meds (gentamicin, vancomycin, furosemide)
- MOST COMMON NONHEREDITARY SENSORINEURAL HEARING LOSS: CONGENITAL CMV

Unknown 25%

96
Q

Hearing loss - range

A

Hearing Category - Range (decibel)
Normal -10 to 20
Mild 21 to 40
Moderate 41 to 55
Moderate Severe 56 to 70
Severe 71 to 90
Profound >90

97
Q

Conductive hearing loss

A

Path: interference in transmission of sound from external auditory canal to normal inner ear

S/t fluid in middle ear (MOST COMMON), microtia, canal stenosis, stapes fixation

Bone conduction good
AIR CONDUCTION POOR

98
Q

Sensorineural hearing loss

A

Path: abnormal development or damage to cochlear hair cells or auditory nerve

BONE + AIR CONDUCTION POOR

99
Q

Auditory dyssynchrony = Auditory neuropathy

A

Less common

Inner ear or cochlea receive songs appropriately, but auditory processing FROM COCHLEA TO AUDITORY NERVE abnormal

More severe sound and speech abnormalities than predicted by degree of hearing loss
Unknown cause

100
Q

Central hearing loss

A

Auditory canal and inner ear intact with normal sensory and neural pathways, but auditory processing at HIGHER LEVELS WITHIN CNS abnormal

101
Q

Hearing loss - diagnosis?

A

90% detected in newborn period

2 screening methods in newborn period: automated brain response (ABR) and evoked otoacoustic emissions (EOAE)
>= 35 dB = abnormal screen

102
Q

Automated brain response (ABR)

A

> = 35 dB = abnormal screen
- Measures EEG waves generated by auditory system in response to clicks via 3 electrodes on scalp
- Reliable after 34 weeks
- Preferred initial screening method for NICU grad d/t ability to detect auditory dyssynchrony

103
Q

Evoked otoacoustic emissions (EOAE)

A

> = 35 dB = abnormal screen
- Measures acoustic feedback from cochlea through ossicles to tympanic membrane and ear canal after click stimulus
- Quicker than ABR
- More likely affected by debris or fluid in external and/or middle ear -> higher referral rates
- Can’t detect some sensorineural hearing loss

104
Q

Hearing loss - management?

A
  • If fail EOAE -> consider ABR ptd
  • If unable to perform ABR -> rescreen within 10 days of original test w/ ABR at auditory center with expanded dB ranges

If still positive for hearing loss:
- Otolaryngologist consult
- Genetic eval if no known cause
- Early intervention referral prior to 3 months PMA
- Ophthalmology to eval another sensory loss
- Determine ideal mode of assistance: amplification system, cochlear implant (esp if profound bilateral loss available as early as age 1 year)

105
Q

Hearing loss - outcome?

A

2-7% infants initial screen will refer
Of referrals, 80% prescreen normal hearing; 20% true hearing deficit

Critical window of neuroplasticity during first 3 years
Earlier habilitation initiated -> greater chance achieving age-appropriate language and communication skills

106
Q

Learning disability

A

Def: deficit psychological process w/ imperfect ability to listen, speak, read, write, spell, do math
- Significant discrepancy btw learning potential and actual academic achievement
- Must exclude mental deficiency, deafness, lack of opportunity

Epi: 2 peaks
1) Early elementary - reading, spelling, math
2) Late elementary - concept classes

Clinical:
Must be at least 1 std dev or 15-point difference btw scores on standardized intelligence test (higher) and standardized achievement test (lower)
Present any age

107
Q

what is congenital hypoplasia of depressor angularis oris muscle ?

A

facial palsy. but only impact lower face.

108
Q

What type of brain development occurs at 34 to 40 weeks?

A

Increase in cerebral volume
Increase in cortical surface area
Maturation of cell types - oligodendrocytes, microglia, astrocytes
GABA-nergic neurons migrate to cortex

109
Q

At what gestational age does the fetus first respond to sound?

A

20 to 25 weeks

110
Q

Congenital glaucoma - genetics, path, signs and symptoms?

A

Genetics: AR
Male > Female
Caused by abnormalities in drainage of aqueous humor in anterior eye -> increased ocular pressure

Presents within first 6 months of life

Signs and symptoms:
- Tearing
- Photophobia
- Enlarged globe (buphophthalmos)
- Corneal edema
- Corneal clouding -> irregular corneal light reflex (leukocoria) and dull red reflex
- Vision loss
- Conjunctival injection

111
Q

What congenital infection presents with leukocoria?

A

Rubella -> bilateral cataracts

112
Q

What congenital infection presents with chorioretinitis?

A

CMV
Toxoplasmosis (can also have cataract, like Rubella)

113
Q

What are the language milestones at-
1 to 6 months?
4 to 6 months?
5 to 7 months?
10 months?
15 to 18 months?

A

1 to 6 months: Cooing “ooh” “aah”

4 to 6 months: Vocal play / expansion stage - consonant and vowel sounds

5 to 7 months: Babbling - forms sounds with “b” “m” “p”
*lack of babbling by 11 months warrants audiologic evaluation

10 months: Jargon / intonated babbling - well formed vowel syllables

15 to 18 months: Echolalia / repetitive sounds

114
Q

What is the functional development of the eye at-
30 to 32 weeks?
Term?
2 months?
3 months?
6 months?
24 months?

A

30 to 32 weeks red reflex [tests afferent and efferent pathways of CN III (oculomotor)]

Term: conjugate HORIZONTAL gaze, visual fixation (well developed at 2 months of age)

2 months: conjugate VERTICAL gaze

3 months: well developed vision

6 months: visual evoked potentials reach adult levels

24 months: optic nerve myelination complete

115
Q

What CN is responsible for ptosis?

A

CN III (oculomotor) - leading to abnormal function of levator palpebral muscle

Ptosis: inability of eyelid to rise to normal level leading to decreased vertical space btw upper and lower lids
- unilateral or bilateral

My board review cards (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions